A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food
Status:
Not yet recruiting
Trial end date:
2023-01-26
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to compare a tablet and a capsule form of tafamidis
without food and to assess the amount of tafamidis in blood after taking the tablet form with
food.
This study is seeking healthy participants over the age of 18.
All participants in the study will receive either one tablet or capsule of study medicine on
the first day without food, then receive one dose of the other tablet or capsule form 16 days
later without food. All participants will then receive one dose of the tablet form with food
16 days later.
We will evaluate the amounts in blood for 8 days after taking each dose of the study
medicine.
Participants will take part in this study for about 96 days. The first visit is a screening
visit to ensure that participants are appropriate for the study. Up to 28 days later,
eligible participants will visit the study clinic three times (and stay overnight in the
clinical research center for 8 nights each time). The study team will also call participants
over the phone 28 to 35 days after the last dose of medicine.